APLM Apollomics Inc.

Nasdaq N/A


$ 23.93 nm (nm)    

Friday, 14-Nov-2025 15:49:27 EST
QQQ $ 608.53 $ 0.46 (0.08 %)
DIA $ 471.77 $ -2.94 (-0.62 %)
SPY $ 671.64 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.87 $ -6.91 (-1.8 %)
$ 20.96
$ 23.92
$ 22.42 x 30
$ 24.81 x 60
$ 22.50 - $ 24.60
$ 3.66 - $ 42.12
55,923
na
23.13M
$ 0.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 apollomics-receives-39m-payment-from-launxp-maintains-active-collaboration-on-vebreltinib-development

Pursuant to the Company's Form 6-K filed on July 25, 2025 (the "July 2025 6-K"), Apollomics Inc. ("Apollomics&#...

 nasdaq-cancels-delisting-hearing-for-apollomics-confirms-compliance-with-continued-listing-standards

Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a California based late-stage clinical biopharma...

Core News & Articles

The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading will resume in Apollomics Inc. Class A ordinary shares (NASDAQ:AP...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION